Table 1. Guanylate cyclase and cADPR antagonists suppress NO inactivation of IK,in and [Ca2+]i elevation.
Treatment | IK,in (pA) | [Ca2+]i resting (nM) | [Ca2+]i evoked (nM) |
---|---|---|---|
Control | -517 ± 53 (27) | 159 ± 15 (6) | 452 ± 31 (6) |
10 μM SNAP | -151 ± 35 (27) | 262 ± 31 (6) | 741 ± 70 (6) |
+1 μM ryanodine* | -535 ± 72 (5) | 171 ± 11 (3) | 200 ± 12 (3) |
+20 μM ODQ | -443 ± 36 (5) | 106 ± 26 (4) | 303 ± 68 (4) |